Stockscreener 앱 받기
3.61
2.56%
0.09
시간 외 거래:
3.61
Evolent Health Inc 주식(EVH)의 최신 뉴스
US30050BAG6 Bond Profile: Coupon and Redemption - TradingView
EVH6495551 Bond Profile: Coupon and Redemption - TradingView
Evolent Health (EVH) Short Interest & Short Float | Updated Sep 2026 $EVH - MarketBeat
Evolent Health, Inc. (EVH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Evolent Health stock gains on a TransPerfect expansion - AD HOC NEWS
3 Reasons to Avoid EVH and 1 Stock to Buy Instead - Yahoo Finance
Evolent Health expands language services deal with TransPerfect By Investing.com - Investing.com Nigeria
Evolent Health expands language services deal with TransPerfect - Investing.com
TransPerfect Wins Evolent Telephonic Interpretation Deal - TradingView
Q2 Healthcare Technology for Providers Earnings: Evolent Health (NYSE:EVH) Impresses - Yahoo Finance
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Evolent program flags low-value regimen years ahead of failed clinical trial - RamaOnHealthcare
Morgan Stanley slips under 5% in Evolent Health (NYSE: EVH) - Stock Titan
EVH6495551 Latest News and Headlines - TradingView
Evolent Health (EVH) President Daniel Mccarthy Sells 65,892 Shar - GuruFocus
Evolent Health President Daniel Joseph McCarthy sells 65,892 shares for $329,460 - Bitget
EVH6495551 Bond Yield and Price — FINRA:EVH6495551 - TradingView
Evolent Health (EVH) Institutional Ownership 2026 $EVH - MarketBeat
Evolent Health (NYSE: EVH) officer lines up 2026 stock sale - Stock Titan
EVH | Evolent Health, Inc Class FinancialsRevenue Breakdown - quiverquant.com
EVH Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus
EVH Maintained by TD Cowen -- Price Target Raised to $6.00 - GuruFocus
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $6 - Moomoo
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance UK
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance
EVH Q2 2026 Earnings: EPS Swing to Positive Territory Delivers 183.68% SurpriseEarnings Surprise Stocks - careplusvn.com
Evolent Health (NYSE:EVH) Shares Up 10%What's Next? - marketbeat.com
Evolent Health (EVH) Q2 2026 Earnings Call Transcript - The Globe and Mail
Evolent Health rated Buy despite heavy debt and losses, betting on strong growth by 2027. - Pluang
Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH) - Seeking Alpha
Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH) - The Globe and Mail
Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH - marketbeat.com
EVH Maintained by Truist Securities -- Price Target Lowered to $6.00 - GuruFocus
Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - marketbeat.com
Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Cuts Target Price to $6 - Moomoo
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Australia
Truist cuts Evolent Health stock price target on execution risks - Investing.com
Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating - marketscreener.com
Evolent Health Shares Rise After Citigroup Upgrade - marketscreener.com
EVH Upgraded by Citigroup -- Price Target Lowered to $6.00 - GuruFocus
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Evolent Health, Inc. (EVH) Stock Analysis: A Healthcare Tech Player with a 46% Potential Upside - DirectorsTalk Interviews
Evolent Health Price Target Cut to $6.00/Share From $7.00 by Canaccord Genuity - Moomoo
Citi Upgrades Evolent Health(EVH.US) to Buy Rating, Cuts Target Price to $6 - Moomoo
Evolent Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:EVH) 2026-08-10 - Seeking Alpha
EVH Looks 60.0% Undervalued on GF Value™ Despite Profitability C - GuruFocus
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com Nigeria
0.03%
0.40%
자본화:
|
볼륨(24시간):